Similar cardiovascular risk factor profile in screen-detected and known type 2 diabetic subjects

References

• UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res 1990;13:1–11.
   PubMedGoogle Scholar
• Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, . Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683–9.
   PubMed Web of Science ®Google Scholar
• Harris R, Donahue K, Rathore SS, Frame P, Woolf SH, Lohr KN. Screening adults for type 2 diabetes: A review of the evidence for the US Preventive Services Task Force. Ann Intern Med 2003;138:215–29.
   PubMed Web of Science ®Google Scholar
• Glumer C, Jorgensen T, Borch-Johnsen K. Prevalences of diabetes and impaired glucose regulation in a Danish population: The Inter99 study. Diabetes Care 2003;26:2335–40.
   PubMed Web of Science ®Google Scholar
• Diabetes UK. Position statement: Early identification of people with Type 2 diabetes. http://www.diabetes.org.uk/infocentre/state/downloads/earlyid.doc, accessed November 3 2009.
   Google Scholar
• American Diabetes Association. Screening for type 2 diabetes: Position statement. Diabetes Care 2004;27(Suppl 1): S11–4.
   Google Scholar
• Wareham NJ, Griffin SJ. Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. BMJ 2001;322:986–8.
   PubMed Web of Science ®Google Scholar
• Feig DS, Palda VA, Lipscombe L. Screening for type 2 diabetes mellitus to prevent vascular complications: Updated recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2005;172:177–80.
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998;317: 703–13.
   PubMed Web of Science ®Google Scholar
• Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, . Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755–62.
   PubMed Web of Science ®Google Scholar
• Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997;20:614–20.
   PubMed Web of Science ®Google Scholar
• Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus: Provisional report of a WHO consultation. Diabet Med 1998;15: 539–53.
   PubMed Web of Science ®Google Scholar
• Heldgaard PE, Olivarius NF, Hindsberger C, Henriksen JE. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: Population-based, cross-sectional study of risk factors for cardiovascular disease. Diabet Med 2004;21:363–70.
   PubMedGoogle Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc Series B 1995;57:289–300.
   Web of Science ®Google Scholar
• Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 1992;15:815–19.
   PubMed Web of Science ®Google Scholar
• Sandbaek A, Griffin SJ, Rutten G, Davies M, Stolk R, Khunti K, . Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk: The ADDITION study. Diabetologia 2008;51:1127–34.
   PubMed Web of Science ®Google Scholar
• Spijkerman AM, Dekker JM, Nijpels G, Adriaanse MC, Kostense PJ, Ruwaard D, . Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: The Hoorn Screening Study. Diabetes Care 2003;26:2604–8.
   PubMed Web of Science ®Google Scholar
• Spijkerman AM, Henry RM, Dekker JM, Nijpels G, Kostense PJ, Kors JA, . Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: The Hoorn Screening Study. J Intern Med 2004;256:429–36.
   PubMedGoogle Scholar
• Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, . Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 1998;21:518–24.
   PubMed Web of Science ®Google Scholar
• Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, . American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003;9:237–52.
   PubMedGoogle Scholar
• Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 2009;32:2297–9.
   PubMed Web of Science ®Google Scholar
• Olivarius N de F, Andreasen AH, Siersma V, Richelsen B, Beck-Nielsen H. Changes in patient weight and the impact of antidiabetic therapy during the first 5 years after diagnosis of diabetes mellitus. Diabetologia 2006;49:2058–67.
   PubMedGoogle Scholar
• Olivarius N de F, Richelsen B, Siersma V, Andreasen AH, Beck-Nielsen H. Weight history of patients with newly diagnosed Type 2 diabetes. Diabet Med 2008;25:933–41.
   PubMedGoogle Scholar
• Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. American College of Physicians, Part 1. Ann Intern Med 1996;124:515–17.
   PubMedGoogle Scholar
• LaRosa JC, Pearson TA. Cholesterol screening guidelines consensus, evidence, and the departure from common sense. Circulation 1997;95:1651–3.
   PubMedGoogle Scholar
• Danielsson B, Vancheri F, Aberg H, Strender LE. Hyperlipidaemia: Differences in management practices and attitudes in two regions in Europe––Sicily and the Stockholm area. Eur J Epidemiol 1998;14:477–82.
   PubMedGoogle Scholar
• Cederholm J, Eliasson B, Nilsson PM, Weiss L, Gudbjornsdottir S. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clin Pract 2005;67: 258–66.
   PubMed Web of Science ®Google Scholar
• Nagi DK, Mohamed A, V, Jain SK, Walji S, Yudkin JS. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians. Diabet Med 1996;13:59–64.
   PubMedGoogle Scholar
• Yach D, Alberti G. Screening for Type 2 diabetes. Report of a World Health Organization and International Diabetes Federation Meeting. Report No. WHO/NMH/MNC/03.1. Geneva: World Health Organization; 2003.
   Google Scholar
• Heldgaard PE, Griffin SJ. Routinely collected general practice data aids identification of people with hyperglycaemia and metabolic syndrome. Diabet Med 2006;23: 996–1002.
   PubMedGoogle Scholar
• Wilson JMG JG. Principles and practice of screening for disease. World Health Organisation; 1968. Report No. 34. http://whqlibdoc.who.int/php/WHO_PHP_34.pdf (accessed February 14, 2011).
   Google Scholar
• Spigt M, Rikkers A, Doornbos M, Wouters E, Spitz I, Van AL, . The effect of screening on the prevalence of diagnosed type 2 diabetes in primary care. Scand J Prim Health Care 2009;27:232–7.
   PubMed Web of Science ®Google Scholar
• Juul L, Sandbaek A, Foldspang A, Frydenberg M, Borch-Johnsen K, Lauritzen T. Adherence to guidelines in people with screen-detected type 2 diabetes, ADDITION, Denmark. Scand J Prim Health Care 2009;27:223–31.
   PubMed Web of Science ®Google Scholar